Alert
This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.
Hōtaka akoranga Our work
Full A–Z list Our programmes
Ā mātou raraunga Our data
Full A–Z list
Ngā rauemi Resources
Whare rauemi Resource library
Te Pū rauemi KOWHEORI-19 COVID-19 resource hub

Support for people working in health during the COVID-19 pandemic. Find information about how you can support yourselves and others, including consumers, teams and colleagues which complements and aligns with Ministry of Health resources.

Kia āta kōwhiri Choosing Wisely

The Choosing Wisely campaign seeks to reduce harm from unnecessary and low-value tests and treatment.

Published articles
Back to previous page

Open Book: Alert for prescribing error – dabigatran and enoxaparin (July 2017)

Adverse events PDF
15 Dec 2021

This report alerts providers to adverse event cases reported to the Commission’s Adverse Events Learning Programme.

It highlights the risks when prescribers are unaware of the requirements for prescribing dabigatran or switching between enoxaparin (Clexane) and dabigatran (Pradaxa).

The requirements are different to when starting warfarin or switching between warfarin and enoxaparin.

Attachments

Relevant pages

Adverse events

Published: 15 Dec 2021 Modified: 15 Dec 2021